Dual effects of cycloheximide on U937 apoptosis induced by its combination with VP-16

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 7, 2004, Pages 1075-1080

  Wu, Rong Cong ^a   Chen, Di Fei ^a   Liu, Ming Jie ^a   Wang, Zhao ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle distribution; Cycloheximide; Human leukemic U937 cell; N tosyl L lysylchloromethyl ketone (TLCK); VP 16

Indexed keywords

CYCLOHEXIMIDE; ETOPOSIDE; SERINE PROTEINASE INHIBITOR; TOSYLLYSYL CHLOROMETHYL KETONE; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL CYCLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN CELL; PROTEIN SYNTHESIS; T LYMPHOCYTE; CELL PROLIFERATION; CELL STRAIN U937; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL PROLIFERATION; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; HUMANS; U937 CELLS;

EID: 16644377778     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1075     Document Type: Article

References (23)

1. Jacobson M. D., Weil M., Raff M. C., Cell, 88, 347-354 (1997).
2. Nagata S., Cell, 88, 355-365 (1997).
3. Thompson C., Science, 267, 1456-1462 (1995).
4. Hanahan D., Weinberg R. A., Cell, 100, 57-70 (2000).
5. Lowe S. W., Lin A. W., Carcinogenesis, 21, 485-495 (2000).
6. Guo Y.-L., Baysal K., Kang B., Yang L.-J., Williamson J. R., J. Biol. Chem., 273, 4027-4034 (1998).
7. Fulda S., Meyer E., Debatin K.-M., Cancer Res., 60, 3947-3956 (2000).
8. Coxon F. P., Benford H. L., Russell R. G. G., Rogers M. J., Mol. Pharmacol., 54, 631-638 (1998).
9. Lemaire C., Andreau K., Souvannavong V., Adam A., Biochem. Pharmacol., 58, 85-93 (1999).
10. Taylor M. H., Buckwalter M. R., Stepheson A. C., Hart J. L., Taylor B. J., O'Neill K. L., FEBS Lett., 514, 199-203 (2002).
11. Tang D., Lahti J. M., Grenet J., Kidd V. J., J. Biol. Chem., 274, 7245-7252 (1999).
12. Martin S. J., Lennon S. V., Bonham A. M., Cotter T. G., J. Immunol., 145, 1859-1867 (1990).
13. Sun X. M., MacFarlance M., Zhuang J., Wolf B. B., Green D. R., Cohen G. M., J. Biol. Chem., 274, 5053-5060 (1999).
14. Bicknell G. R., Snowden R. T., Cohen G. M., J. Cell Sci., 107, 2483-2489 (1994).
15. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C., J. Immunol. Meth., 139, 271-279 (1991).
16. van Engeland M., Nieland L. J. W., Rameakers F. C. S., Schutte B., Reutelingsperger C. P. M., Cytometry, 31, 1-9 (1998).
17. Karpinich N. O., Tafani M., Rothman R. J., Russo M. A., Farber J. L., J. Biol. Chem., 277, 16547-16552 (2002).
18. Sleiman R. J., Stewart B. W., Clin. Cancer Res., 6, 3756-3765 (2000).
19. Gong J.-P., Li X., Darzynkiewicz Z., J. Cell. Physiol., 157, 263-270 (1993).
20. Kumar S., Harvey N. L., FEBS Lett., 375, 169-173 (1995).
21. Lu Q., Mellgren R. L., Arch. Biochem. Biophys., 334, 175-181 (1996).
22. Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.-T., J. Biol. Chem., 274, 7987-7992 (1999).
23. Blass M., Kronfeld I., Kazimirsky G., Blumberg P. M., Brodie C., Mol. Cell. Biol., 22, 182-195 (2002).